Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin

Inicio | ¿Qué es? | Contacto

English | Català

Consultar RECERCAT

Por comunidades y
colecciones Por fecha Por autores Por títulos Por temas (CDU)

Consultar departamento

Por fecha Por autores Por títulos Por temas (CDU)

Estadisticas

Del documento Todo RECERCAT

Mi RECERCAT

Entrar Alertas por correo-e

Directorio de otros repositorios

RECERCAT Principal > Universitat de Barcelona > Economia > Articles publicats en revistes (Economia ) > Visualizar documento

Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/133877

dc.contributor	Universitat de Barcelona
dc.contributor.author	Sicras Mainar, Antoni
dc.contributor.author	Rejas, Javier
dc.contributor.author	Pérez-Paramo, Maria
dc.contributor.author	Sánchez-Alvarez, Luis
dc.contributor.author	Navarro-Artieda, Ruth
dc.contributor.author	Darbà, Josep
dc.date	2019-05-24T07:41:53Z
dc.date	2019-02
dc.date	2019-05-24T07:41:53Z
dc.date	info:eu-repo/date/embargoEnd/2020-02-28
dc.identifier.citation	1473-7167
dc.identifier.citation	686010
dc.identifier.uri	http://hdl.handle.net/2445/133877
dc.format	13 p.
dc.format	application/pdf
dc.language.iso	eng
dc.publisher	Informa Healthcare
dc.relation	Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2019.1519399
dc.relation	Expert Review of Pharmacoeconomics & Outcomes Research, 2019, vol. 19, num. 1, p. 45-57
dc.relation	https://doi.org/10.1080/14737167.2019.1519399
dc.rights	(c) Informa Healthcare, 2019
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.subject	Medicaments
dc.subject	Medicaments genèrics
dc.subject	Anàlisi cost-benefici
dc.subject	Neuropsicofarmacologia
dc.subject	Tractament del dolor
dc.subject	Ansietat
dc.subject	Drugs
dc.subject	Generic drugs
dc.subject	Cost effectiveness
dc.subject	Neuropsychopharmacology
dc.subject	Pain treatment
dc.subject	Anxiety
dc.title	Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/acceptedVersion
dc.description.abstract	Background: Discrepancies are seen between arguments in favor of and against prescribing generic versus brand-name drugs. Objective: To provide real-world evidence on treatment persistence, economic and clinical outcomes of pregabalin, generic versus brand-name (Lyrica®, Pfizer), routinely used to treat neuropathic pain (NP) or generalized anxiety disorder (GAD). Methods: Electronic medical records from subjects' first starting treatment with pregabalin between January-2015 and June-2016 were analyzed. Persistence, resources utilization, and costs were assessed, along with remitter and responder rates. (...)

Mostrar el registro sencillo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin

Sicras Mainar, Antoni; Rejas, Javier; Pérez-Paramo, Maria; Sánchez-Alvarez, Luis; Navarro-Artieda, Ruth; Darbà, Josep

Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis

Sicras Mainar, Antoni; Sánchez-Álvarez, Luis; Navarro-Artieda, Ruth; Darbà, Josep

Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study

Darbà, Josep; Kaskens, Lisette; Pérez Álvarez, Núria; Palacios Ruiz, Lucas Santiago; Neyro, José Luis; Rejas, Javier

Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance

Darbà, Josep; Ramírez, Gabriela; Sicras Mainar, Antoni; García-Bujalance, Laura; Torvinen, Saku; Sánchez de la Rosa, Rainel

Accesibilidad | Aviso legal | Política de Cookies | Documentos de uso interno

Coordinación

Patrocinio